Developing TRAIL/TRAIL death receptor-based cancer therapies
Developing TRAIL/TRAIL death receptor-based cancer therapies
About this item
Full title
Author / Creator
Yuan, Xun , Gajan, Ambikai , Chu, Qian , Xiong, Hua , Wu, Kongming and Wu, Gen Sheng
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can initiate the apoptosis pathway by binding to its associated death receptors DR4 and DR5. The activation of the TRAIL pathway in inducing tumor-selective apoptosis leads to the development of TRAIL-based cancer therapies, which include r...
Alternative Titles
Full title
Developing TRAIL/TRAIL death receptor-based cancer therapies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6138568
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6138568
Other Identifiers
ISSN
0167-7659
E-ISSN
1573-7233
DOI
10.1007/s10555-018-9728-y
